APA

Aritake S., Kusakabe K., Kanaya S., Kanaya K., Nakano K., Ota T., Maki M. & Shigeta A. (19930416). [131I-therapy of differentiated thyroid carcinoma with distant metastases--relation between absorbed dose by quantitative SPECT and outcome of the patients in thyroid carcinoma]. : Kaku igaku. The Japanese journal of nuclear medicine.

Chicago

Aritake S, Kusakabe K, Kanaya S, Kanaya K, Nakano K, Ota T, Maki M and Shigeta A. 19930416. [131I-therapy of differentiated thyroid carcinoma with distant metastases--relation between absorbed dose by quantitative SPECT and outcome of the patients in thyroid carcinoma]. : Kaku igaku. The Japanese journal of nuclear medicine.

Harvard

Aritake S., Kusakabe K., Kanaya S., Kanaya K., Nakano K., Ota T., Maki M. and Shigeta A. (19930416). [131I-therapy of differentiated thyroid carcinoma with distant metastases--relation between absorbed dose by quantitative SPECT and outcome of the patients in thyroid carcinoma]. : Kaku igaku. The Japanese journal of nuclear medicine.

MLA

Aritake S, Kusakabe K, Kanaya S, Kanaya K, Nakano K, Ota T, Maki M and Shigeta A. [131I-therapy of differentiated thyroid carcinoma with distant metastases--relation between absorbed dose by quantitative SPECT and outcome of the patients in thyroid carcinoma]. : Kaku igaku. The Japanese journal of nuclear medicine. 19930416.